Emerging Triple Inhibitor Combination Targets Malignant Peripheral Nerve Sheath Tumors: A Breakthrough in Precision Medicine
A groundbreaking multicenter collaboration spearheaded by the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO), and the ...